Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Doptelet (avatrombopag)
.
Show all posts
Showing posts with label
Doptelet (avatrombopag)
.
Show all posts
Monday, December 23, 2019
Dova Pharmaceuticals Announces FDA Approval of Doptelet (avatrombopag) for Treatment of Chronic Immune Thrombocytopenia (ITP)
›
In continuation of my update on avatrombopag Dova Pharmaceuticals, Inc. a pharmaceutical company focused on acquiring, developi...
Thursday, July 19, 2018
FDA Approves Doptelet (avatrombopag) for Chronic Liver Disease Patients with Thrombocytopenia who are Undergoing a Medical Procedure
›
The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia...
›
Home
View web version
